Movatterモバイル変換

[0]ホーム
URL:

ES2669585T3 - Micropartículas porosas de silicio para la entrega de fármaco para el ojo - Google Patents

Micropartículas porosas de silicio para la entrega de fármaco para el ojoDownload PDF

Info

Publication number
ES2669585T3
ES2669585T3ES05819498.6TES05819498TES2669585T3ES 2669585 T3ES2669585 T3ES 2669585T3ES 05819498 TES05819498 TES 05819498TES 2669585 T3ES2669585 T3ES 2669585T3
Authority
ES
Spain
Prior art keywords
eye
drug delivery
porous silicon
silicon microparticles
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES05819498.6T
Other languages
English (en)
Inventor
William Freeman
Michael Sailor
Lingyun Cheng
Frederique Cunin
Emily Anglin
Yang Yang Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSDfiledCriticalUniversity of California Berkeley
Application grantedgrantedCritical
Publication of ES2669585T3publicationCriticalpatent/ES2669585T3/es
Activelegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Classifications

Landscapes

Abstract

Un dispositivo para entrega de fármaco, para el uso en la entrega controlada de un fármaco o fármacos particular(es) a una ubicación particular del ojo, donde el dispositivo comprende: partículas porosas de silicio o dióxido de silicio con tamaño de micrones, que tienen poros configurados y dimensionados para recibir por lo menos parcialmente por lo menos un fármaco dentro de ellos; y en el que las partículas son adecuadas para ser entregadas dentro o sobre el ojo.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9

Claims (1)

ES05819498.6T2004-10-292005-10-31Micropartículas porosas de silicio para la entrega de fármaco para el ojoActiveES2669585T3 (es)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US62340904P2004-10-292004-10-29
US623409P2004-10-29
PCT/US2005/039177WO2006050221A2 (en)2004-10-292005-10-31Porous photonic crystals for drug delivery to the eye

Publications (1)

Publication NumberPublication Date
ES2669585T3true ES2669585T3 (es)2018-05-28

Family

ID=36319719

Family Applications (1)

Application NumberTitlePriority DateFiling Date
ES05819498.6TActiveES2669585T3 (es)2004-10-292005-10-31Micropartículas porosas de silicio para la entrega de fármaco para el ojo

Country Status (5)

CountryLink
US (3)US20090208556A1 (es)
EP (2)EP3381446A1 (es)
DK (1)DK1817003T3 (es)
ES (1)ES2669585T3 (es)
WO (1)WO2006050221A2 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB9808052D0 (en)1998-04-171998-06-17Secr DefenceImplants for administering substances and methods of producing implants
US8765484B2 (en)2002-02-072014-07-01The Regents Of The University Of CaliforniaOptically encoded particles
ES2669585T3 (es)2004-10-292018-05-28The Regents Of The University Of CaliforniaMicropartículas porosas de silicio para la entrega de fármaco para el ojo
JP6067207B2 (ja)2007-07-102017-01-25ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア選択した組織へ組成物を送達するための材料と方法
US8623395B2 (en)2010-01-292014-01-07Forsight Vision4, Inc.Implantable therapeutic device
SG173167A1 (en)2009-01-292011-08-29Forsight Labs LlcPosterior segment drug delivery
AU2010246067B2 (en)2009-05-042016-07-07Eyepoint Pharmaceuticals Us, Inc.Porous silicon drug-eluting particles
WO2013022801A1 (en)2011-08-052013-02-14Forsight Vision4, Inc.Small molecule delivery with implantable therapeutic device
LT2600930T (lt)2010-08-052021-04-12Forsight Vision4, Inc.Injekcinis aparatas, skirtas vaisto tiekimui
JP6111194B2 (ja)2010-08-052017-04-05フォーサイト・ビジョン フォー・インコーポレーテッド組み合わせ薬物送達方法および装置
WO2012019176A2 (en)2010-08-052012-02-09Forsight Vision4 Inc.Implantable therapeutic device
CA2816576C (en)2010-11-012020-06-02Psivida Us, Inc.Bioerodible silicon-based devices for delivery of therapeutic agents
WO2012068549A2 (en)2010-11-192012-05-24Forsight Vision4, Inc.Therapeutic agent formulations for implanted devices
US9394369B2 (en)2011-01-032016-07-19The Regents Of The University Of CaliforniaLuminescent porous silicon nanoparticles for targeted delivery and immunization
WO2013003620A2 (en)2011-06-282013-01-03Forsight Vision4, Inc.Diagnostic methods and apparatus
EP3903733A1 (en)2011-09-162021-11-03ForSight Vision4, Inc.Fluid exchange apparatus
FR2988721B1 (fr)2012-03-272014-04-04Centre Nat Rech ScientNanoparticules de silicium poreux fonctionnalisees et leurs utilisations en therapie photodynamique
US20160002272A1 (en)*2013-02-252016-01-07The Regents Of The University Of CaliforniaSurface functionalized porous silicon material and method of making thereof
US9968603B2 (en)2013-03-142018-05-15Forsight Vision4, Inc.Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
EP2968571A4 (en)2013-03-152016-09-07Psivida Inc BIODEGRADABLE SILICONE BASED COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS
AU2014241163B2 (en)2013-03-282018-09-27Forsight Vision4, Inc.Ophthalmic implant for delivering therapeutic substances
AU2015301054B2 (en)2014-08-082020-05-14Forsight Vision4, Inc.Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
KR20170106298A (ko)2014-11-102017-09-20포사이트 비젼4, 인크.확장 가능한 약물 전달 장치 및 이용 방법
US10702474B2 (en)2015-07-092020-07-07The Regents Of The University Of CaliforniaFusogenic liposome-coated porous silicon nanoparticles
MX2018006234A (es)2015-11-202018-08-14Forsight Vision4 IncEstructuras porosas para dispositivos de suministro de medicamentos de liberacion prolongada.
WO2019103906A1 (en)2017-11-212019-05-31Forsight Vision4, Inc.Fluid exchange apparatus for expandable port delivery system and methods of use
EP3773730A4 (en)2018-03-272021-12-29The Regents of The University of CaliforniaDrug delivery formulations
GB201904337D0 (en)*2019-03-282019-05-15Sisaf LtdA delivery system
GB201904334D0 (en)2019-03-282019-05-15Sisaf LtdCarrier system for preparing herbaceous extracts
CN114948864A (zh)*2021-02-262022-08-30奈力生医股份有限公司用于将药剂递送到眼后段的方法和其用途
USD1033637S1 (en)2022-01-242024-07-02Forsight Vision4, Inc.Fluid exchange device
WO2024249553A1 (en)2023-05-312024-12-05University Of TartuMolecules targeting infected tissues and methods of use thereof

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2674743A (en)*1950-09-211954-04-13Romey A GaiserTherapeutic, cosmetic, and corrective device
US3828777A (en)*1971-11-081974-08-13Alza CorpMicroporous ocular device
JPS56135416A (en)*1980-03-271981-10-22Mitsubishi Chem Ind LtdPharmaceutical preparation for skin
CA1311686C (en)*1986-06-251992-12-22John Weldon ShellControlled release bioerodible drug delivery system
US4906476A (en)*1988-12-141990-03-06Liposome Technology, Inc.Novel liposome composition for sustained release of steroidal drugs in lungs
US5296228A (en)*1992-03-131994-03-22Allergan, Inc.Compositions for controlled delivery of pharmaceutical compounds
US5242950A (en)*1992-04-231993-09-07Somerset Pharmaceuticals, Inc.Treatment of macular degeneration
RU2055555C1 (ru)*1992-05-071996-03-10Михаил Ефимович МаргусУстройство для лечения глазных болезней
GB9611437D0 (en)1995-08-031996-08-07Secr DefenceBiomaterial
GB9808052D0 (en)*1998-04-171998-06-17Secr DefenceImplants for administering substances and methods of producing implants
US6322865B1 (en)1998-07-132001-11-27Patent Holding CompanyHollow plastic article formed by a gas-assisted injection molding system
GB9815819D0 (en)1998-07-221998-09-16Secr DefenceTransferring materials into cells and a microneedle array
GB9909996D0 (en)1999-05-011999-06-30Secr Defence Briteland The SEE Sharp Kabushiki Kaisha 3-1 OPTICS - PATENTS 09/06/99 22:40:35 PAGE 40 NUMBER: 5747 30 JUNE 1999 cations For Patents retary of State for Defence, The Derivatized porous silicon
AU763168B2 (en)1999-05-012003-07-17Psimedica LimitedDerivatized porous silicon
SE9903958D0 (sv)1999-11-021999-11-02Boerje SellergrenPorous materials for selective binding or transport of molecular guests
GB0008494D0 (en)*2000-04-072000-05-24Secr DefenceMicroprojectile delivery system
GB2365769A (en)*2000-08-182002-02-27Secr DefenceSkin preparations containing silicon
GB0104383D0 (en)*2001-02-222001-04-11Psimedica LtdCancer Treatment
US20020156274A1 (en)*2001-03-162002-10-24Terfloth Gerald J.Process for preparing maytansinol
US6815850B2 (en)*2001-07-102004-11-09International Business Machines CorporationFlux leakage barrier in fluid bearing for disk drive
GB0118689D0 (en)*2001-08-012001-09-19Psimedica LtdPharmaceutical formulation
US20030060878A1 (en)*2001-08-312003-03-27Shadduck John H.Intraocular lens system and method for power adjustment
US7482168B2 (en)2001-09-152009-01-27The Regents Of The University Of CaliforniaPhotoluminescent polymetalloles as chemical sensors
US7042570B2 (en)2002-01-252006-05-09The Regents Of The University Of CaliforniaPorous thin film time-varying reflectivity analysis of samples
US8765484B2 (en)2002-02-072014-07-01The Regents Of The University Of CaliforniaOptically encoded particles
KR20050037992A (ko)*2002-06-052005-04-25유니버시티 오브 플로리다안약 전달 장치
US7942989B2 (en)2002-12-102011-05-17The Regents Of The University Of CaliforniaPorous silicon-based explosive
US7713778B2 (en)*2003-02-132010-05-11Univ CaliforniaNanostructured casting of organic and bio-polymers in porous silicon templates
US7433811B2 (en)2003-05-062008-10-07The Regents Of The University Of CaliforniaDirect patterning of silicon by photoelectrochemical etching
WO2005034725A2 (en)2003-08-142005-04-21The Regents Of The University Of CaliforniaPhotonic sensor particles and fabrication methods
GB0324483D0 (en)*2003-10-212003-11-19Psi Medica LtdComposite material
US20050181049A1 (en)*2003-11-192005-08-18Dong Liang C.Composition and method for enhancing bioavailability
GB2409924A (en)*2004-01-062005-07-13Psimedica LtdMethod of making a silicon-phosphorus composite
WO2006014138A1 (en)*2004-08-032006-02-09Agency For Science, Technology And ResearchPolymer having interconnected pores for drug delivery and method
US7903239B2 (en)*2004-10-192011-03-08The Regents Of The University Of CaliforniaPorous photonic crystal with light scattering domains and methods of synthesis and use thereof
ES2669585T3 (es)*2004-10-292018-05-28The Regents Of The University Of CaliforniaMicropartículas porosas de silicio para la entrega de fármaco para el ojo
JP6067207B2 (ja)2007-07-102017-01-25ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア選択した組織へ組成物を送達するための材料と方法
US9394369B2 (en)*2011-01-032016-07-19The Regents Of The University Of CaliforniaLuminescent porous silicon nanoparticles for targeted delivery and immunization
US9216163B2 (en)*2013-05-202015-12-22Kyorin Pharmaceutical Co., Ltd.Method of inhibiting angiogenesis

Also Published As

Publication numberPublication date
EP1817003A4 (en)2012-06-13
US20130224302A1 (en)2013-08-29
US20090208556A1 (en)2009-08-20
WO2006050221A2 (en)2006-05-11
WO2006050221A3 (en)2007-10-11
DK1817003T3 (en)2018-05-22
EP3381446A1 (en)2018-10-03
US20220000768A9 (en)2022-01-06
EP1817003A2 (en)2007-08-15
US11241380B2 (en)2022-02-08
US20180055765A1 (en)2018-03-01
US8945602B2 (en)2015-02-03
EP1817003B1 (en)2018-02-21

Similar Documents

PublicationPublication DateTitle
ES2669585T3 (es)Micropartículas porosas de silicio para la entrega de fármaco para el ojo
PE20061087A1 (es)Formas farmaceuticas resistente a la rotura con liberacion sostenida
PE20061016A1 (es)Una formulacion solida de dosificacion farmaceutica
ES2505643T3 (es)Galectina para uso en el tratamiento del síndrome del ojo seco
CL2008001103A1 (es)Compuestos derivados de [1,2,3]triazolo[4,5-b]piridin-corboxamidas y [1,2,3]triazolo[4,5-d]pirimidin-carboxamidas, inhibidores de megl y faah; procedimiento de preparacion; composicion farmaceutica; y su uso en el tratamiento de dolores agudos o cronicos, vertigos, vomitos, nauseas, sindrome metabolico, dislipidemia, entre otros.
CL2008001104A1 (es)Compuestos derivados de [1,2,3]triazolo[4,5-b]piridin-carboxamidas y [1,2,3]triazolo[4,5-d]pirimidin-carboxamidas, inhibidores de mgl y faah; procedimiento de preparacion; composicion farmaceutica; y su uso en el tratamiento de delolores agudos o cronicos, vertigos, vomitos, nauseas, sindrome metaloico, dispipidemia, entre otros.
ES2570856T3 (es)Composiciones oftálmicas que contienen una combinación sinérgica de dos polímeros
UY28933A1 (es)Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos
ES2167061T3 (es)Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
CL2010000188A1 (es)Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
SV2008002527A (es)Composicion farmaceutica que contiene gestagenos y/o estrogenos y 5-metil-(6s)-tetrahidrofolato ref. p-sv-80.273/ug
WO2006101815A3 (en)Pharmaceutical compositions comprising polyoxaester and active agents for use with osmotic delivery systems
CO6331425A2 (es)Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida
CL2007001724A1 (es)Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
DK1474109T3 (da)Anvendelse af syntetiske uorganiske nanopartikler som bærere af ophthalmiske lægemidler
ATE494885T1 (de)Feste arzneimittelformulierung und vorrichtung zu ihrer aufbewahrung und kontrollierten abgabe
CL2012000313A1 (es)Composición de dosificación de película que comprende una matriz portadora, entre 2-16 mg de buprenorfina, entre 0,5-5 mg de naloxona y un tampón que proporciona un ph local entre 2-4; procedimiento de preparación; uso en el tratamiento de la dependencia de narcóticos en un usuario.
ES2494316T3 (es)Ingrediente activo novedoso en cicatrización y uso del mismo
CO5700832A2 (es)Suspensiones acuosas de ciclesonide para nebulizacion
DE602005010788D1 (de)Pharmazeutische Zusammensetzungen zur sicheren Verabreichung von bei der Behandlung von Drogenabhängigkeit verwendeten Arzneimitteln
PE20070377A1 (es)Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
EA201001244A1 (ru)Система доставки лекарственного средства со стабилизирующим эффектом
CL2010001362A1 (es)Forma de dosificacion farmaceutica para la liberacion inmediata de la sustancia activa 3-z-[1-(4-(n-((4-metil-piperazin-1-il)-metilcarbonil)-n-metil-amino)-anilino)-1-fenil-metileno]-6-metoxicarbonil-2-indolinona-monoetanosulfonato; y su uso para el tratamiento y/o prevencion de enfermedades oncologicas e inmunologicas, entre otras.
BRPI0510654A (pt)formulações de interferon em hidrogel
DE60128263D1 (de)Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
[8]ページ先頭
©2009-2025 Movatter.jp